NewsLepton signs Consulting Agreement with Dr. Paz Einat

February 1, 2022by admin

Lepton is pleased to announce that the Company has signed a consulting agreement with Dr. Paz Einat for consulting services in the field of development of Lepton’s developmental pharmaceutical therapeutics based on siRNA and/or miRNA.  Dr. Paz Einat is an expert in molecular biology in general (vectorology, gene expression, genomics, directed evolution and more) and drug development, specializing in nucleic-acid based drugs including siRNA & gene therapy.